Healthcare

Prices stabilized and have rallied smartly in the past few weeks.
There are mixed sigs in the charts.
Shares of Intrexon posted modest gains despite reports from an anonymous short-seller.
Major investor testifies before Senate committee investing drug company's practices.
Aggressive traders can go long REGN on the first up day.
Bill Ackman has never been shy in defending his investments, even his fund's biggest flops.
The rate of decline slowed into the base, just what chartists like to see. 
Use a shallow dip to buy GILD as further gains look possible.
BIIB could be headed above $300 over the intermediate term.
Improving momentum suggests we could have an intermediate-term rally, possibly taking CELG above $120.

Columnist Conversations

Coming up!
National Oilwell Varco (NOV) is a big energy equipment maker in the cyclical doldrums. Its balance sheet is st...
Among the famed Danaher (DHR) wannabes in mid-cap industrial land, Colfax (CFX) continues to get pushed around...
Applied Materials is also on a four day losing streak that has pushed shares below the April lows. This f...

REAL MONEY'S BEST IDEAS

News Breaks

Powered by

BROKERAGE PARTNERS

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.


TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.